| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $73K | +20.8% | +131.5% |
| SG&A Expense | $327K | -4.1% | +10.2% |
| Operating Income | -$400K | +0.4% | -21.9% |
| Pre-tax Income | -$400K | +0.4% | -21.9% |
| Net Income | -$400K | +0.4% | -21.9% |
| EPS (Basic) | -$0.02 | +0.0% | +33.3% |
| EPS (Diluted) | -$0.02 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Current Assets | $1.6M | -2.5% | +1435.0% |
| Total Assets | $1.6M | -2.5% | +1415.4% |
| Current Liabilities | $4.5M | +8.1% | +36.0% |
| Total Liabilities | $4.5M | +8.1% | +36.0% |
| Stockholders' Equity | -$2.9M | -14.8% | +8.9% |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$873K | — | — |
| Financing Cash Flow | $882K | — | — |
| +0.0% |
| +33.3% |